Cargando…

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review

INTRODUCTION: In the context of the opioid crisis in North America, the benefits of evidence-based opioid agonist treatments such as buprenorphine/naloxone have not been optimised due to low uptake. Numerous factors contribute to the underuse of buprenorphine, and theory-informed approaches to ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leece, Pamela, Khorasheh, Triti, Corace, Kimberly, Strike, Carol, Bayoumi, Ahmed M, Taha, Sheena, Marks, Elisabeth, Pach, Beata, Ahamad, Keith, Grennell, Erin, Holowaty, Melissa, Manson, Heather, Straus, Sharon E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Addiction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924699/ https://www.ncbi.nlm.nih.gov/pubmed/31843837 http://dx.doi.org/10.1136/bmjopen-2019-032285

Ejemplares similares

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
por: Rice, Danielle B, et al.
Publicado: (2018)

‘Communities are attempting to tackle the crisis’: a scoping review on community plans to prevent and reduce opioid-related harms
por: Leece, Pamela, et al.
Publicado: (2019)

Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial
por: Orkin, Aaron, et al.
Publicado: (2019)

Supporting community overdose response planning in Ontario, Canada: Findings from a situational assessment
por: Khorasheh, Triti, et al.
Publicado: (2022)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
por: Piske, Micah, et al.
Publicado: (2020)

Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports
por: Crowley, Des, et al.
Publicado: (2020)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales
por: Marteau, Dave, et al.
Publicado: (2015)

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study
por: Morin, Kristen A, et al.
Publicado: (2022)

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
por: Scott, Gemma, et al.
Publicado: (2023)

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
por: Guerra-Alejos, B Carolina, et al.
Publicado: (2023)

Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine
por: Webster, Lynn, et al.
Publicado: (2016)

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
por: Suarez, Edward, et al.
Publicado: (2023)

Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection
por: Eller, Anthony J., et al.
Publicado: (2022)

Opioid overdose decedent characteristics during COVID-19
por: Garcia, Gian-Gabriel P., et al.
Publicado: (2022)

Primary care management of Long-Term opioid therapy
por: Coffin, Phillip O., et al.
Publicado: (2022)

A rapid review of current engagement strategies with people who use drugs in monitoring and reporting on substance use-related harms
por: Perri, Melissa, et al.
Publicado: (2023)

Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia
por: Lam, Tina, et al.
Publicado: (2022)

Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022)

Rewarding recovery: the time is now for contingency management for opioid use disorder
por: Proctor, Steven L.
Publicado: (2022)

Allostatic load in opioid use disorder: a scoping review protocol
por: Fan, Jaimie Qiuyun, et al.
Publicado: (2023)

Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study
por: Qeadan, Fares, et al.
Publicado: (2022)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Quality of life and relapse of Opioid Use Disorder: a scoping review protocol
por: Namatovu, Angella, et al.
Publicado: (2023)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Contingency management for tobacco smoking during opioid addiction treatment: a randomised pilot study
por: Ainscough, Tom Stephen, et al.
Publicado: (2017)

Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study
por: Just, Johannes Maximilian, et al.
Publicado: (2019)

U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts
por: Bennett, Alex S., et al.
Publicado: (2022)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care
por: Reece, Albert Stuart, et al.
Publicado: (2018)

Risk of behaviour suggestive of opioid abuse: a protocol for a systematic review of validated assessment tools
por: Galindo, Sheila Raposo, et al.
Publicado: (2018)

The changing epidemiology of opioid overdose in Baltimore, Maryland, 2012–2017: insights from emergency medical services
por: Dun, Chen, et al.
Publicado: (2022)

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
por: Andraka-Christou, Barbara, et al.
Publicado: (2023)

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)
por: Allen, Sean T., et al.
Publicado: (2023)

From design to action: participatory approach to capacity building needs for local overdose response plans
por: Mallakin, Maryam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nkpjomhe5gvkuu344tc766jgpt